Dr. Morganroth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 South Dr
Ste 11
Mountain View, CA 94040Phone+1 650-969-5600Fax+1 650-969-0360
Education & Training
- Yale-New Haven Medical CenterResidency, Dermatology, 1991 - 1994
- University of Pennsylvania Health SystemInternship, Internal Medicine, 1990 - 1991
- University of Michigan Medical SchoolClass of 1990
Certifications & Licensure
- CA State Medical License 1995 - 2026
- CT State Medical License 1995 - 1995
- PA State Medical License 1990 - 1991
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Publications & Presentations
PubMed
- 227 citationsBone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.Julie B. Sneddon, Hanson H. Zhen, Kelli Montgomery, Matt van de Rijn, Aaron D. Tward
Proceedings of the National Academy of Sciences of the United States of America. 2006-10-03 - 21 citationsTopical 0.1% alitretinoin gel for classic Kaposi sarcoma.Greg S. Morganroth
Archives of Dermatology. 2002-04-01 - 17 citationsEffects of Epinephrine on Insulin Secretion and Action in Humans: Interaction With AgingLinda Morrow, Greg S Morganroth, William H. Herman, Richard N. Bergman, Jeffrey B. Halter
Diabetes. 1993-02-01
Press Mentions
- Equity Firms Pressure to Sell: What’s Best for YouJanuary 7th, 2016
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: